USSTOCK.TODAY
Weekend. Closed Log in Sign up
ETF Profiles

What Is the REVS ETF? Returns, Fees, Holdings, and Alternative ETFs Explained

Updated June 10, 2026 · First published June 10, 2026

The Columbia Research Enhanced Value ETF (REVS) is a passive product that selects US value stocks through research analysis. Its annual dividend, research-enhanced structure, and differences in selection methods versus related products such as VLUE, JAVA, and FVAL are the key selection criteria.

Briefs · earnings · signals, first Subscribe
🏷️

What Is the Columbia Research Enhanced Value ETF?

This is a passive ETF that applies research-based analysis to select undervalued US value stocks. It places greater weight on value stocks with high research scores, aiming for better performance than a general value index.

It suits value-oriented investors who want exposure to US value stocks screened with research, and who are willing to accept relative weakness during growth-led market phases.

It is an ETF managed by Columbia using a passive (index-tracking) approach.

💰

How Does the Columbia Research Enhanced Value ETF Invest?

ItemDetails
Investment targetUS value stocks
Management stylePassive (research-enhanced index)
Selection criteriaUndervaluation + research score
Dividend frequencyAnnual dividend
Total expense ratio0.19%

The ETF tracks a rules-based index that overweights undervalued US value stocks that research analysis has rated highly. Unlike a simple value index, it adds a research score to screen out undervalued stocks that are more likely to underperform, while keeping costs low.

  • Combines value stocks with a research score
  • Low-cost, rules-based management
📐

Columbia Research Enhanced Value ETF Size and Costs (AUM and Management Fee)

Assets under management (AUM) stand at $414.3M, and the total expense ratio is 0.19% per year.

The main point of comparison is its rules-based selection with an added research score, versus simple value ETFs or actively managed value ETFs.

📈

Columbia Research Enhanced Value ETF Performance and Trends

1-Year Price Performance
Dividend & Yield
Dividend Yield 0.92%
Annual Dividend (TTM) $0.30
1Y Return +21.8%
Next Ex-Dividend Date 12/18/2025
52-Week Price Range
$33
Low $27 High $35
vs. low +21.82% vs. high -7.34%

US value stocks are driven by interest rates, the economic cycle, and style rotation. Value strategies tend to be strong when value stocks are in favor and weak when growth stocks lead. Because a research score is added, performance can differ somewhat from that of a general value index.

Fund flows into value stocks diverge depending on style rotation, risk appetite, and demand for value investing, and money sometimes moves into related products when interest in value investing rises. It is also worth watching how performance shifts with interest rates and style rotation.

⚔️

Columbia Research Enhanced Value ETF Pros and Cons

Research enhancement and low costs are its strengths, while weakness in growth-led phases, tracking differences, and market risk are considerations.

💪 Key Strengths

Research enhancement
A research score is added to screen out undervalued stocks that are more likely to underperform.
Value exposure
It diversifies across undervalued US value stocks to reflect a value orientation.
Low costs
Rules-based management keeps costs lower than those of active funds.

⚠️ Points to Watch

Growth stock weakness
Value strategies can lag in phases led by growth stocks.
Tracking differences
Because of research score selection, performance can diverge from a general value index.
Market risk
If the US stock market falls, losses can occur alongside it.
🔄

Columbia Research Enhanced Value ETF Alternatives and Related Products

For value factor exposure, direct substitutes include VLUE, and for those who want active value management, products such as JAVA are also worth comparing. Investors seeking another form of value factor exposure can also consider products such as FVAL. The three products shown in the table, VLUE, JAVA, and FVAL, differ in selection method across value factor and active value strategies, and this ETF is differentiated by combining value stocks with a research score.

Peer Comparison ETFs
TickerNamePriceChangeAUMTotal Expense RatioDividend Yield1Y
AVUVAVUVAvantis U.S. Small Cap Value ETF$114.40-1.8%$31.0B0.25%1.33%+21.8%
VLUEVLUEiShares MSCI USA Value Factor ETF$170.59-4.0%$8.6B0.15%1.81%+36.8%
JAVAJAVAJPMorgan Active Value ETF$79.37-1.9%$7.2B0.44%1.19%+17.0%
NULVNULVNuveen ESG Large-Cap Value ETF$51.28-2.2%$2.5B0.26%1.44%+17.6%
FVALFVALFidelity Value Factor ETF$75.01-3.0%$1.3B0.15%1.64%+10.3%
Top Holdings
TickerNameWeightPriceChangeMarket CapP/EDividend Yield
AAPLApple Inc0.08%$342.56-1.9%$4.98T38.20.33%
MSFTMicrosoft Corp0.07%$484.52-2.8%$3.60T25.30.81%
BACBank Of America Corp0.04%$47.04-3.1%$324.6B11.22.55%
XOMExxonMobil Holdings Corp0.03%$159.99+0.7%$652.6B16.42.6%
PGProcter & Gamble Co0.03%$169.37+0.9%$392.6B25.52.59%
WFCWells Fargo & Co0.03%$78.62-2.5%$236.0B11.12.42%
GOOGLAlphabet Inc0.03%$265.29-2.7%$3.23T13.80.33%
CSCOCisco Systems Inc0.03%$90.64-4.3%$357.3B24.11.87%
CVXChevron Corp0.03%$208.37+0.9%$409.5B15.33.42%
GOOGAlphabet Inc0.03%$264.00-2.6%$3.24T13.80.33%
✅

Columbia Research Enhanced Value ETF Investor Checkpoints

Here are the points to review before investing in REVS. Research enhancement and low costs are attractive, but relative weakness in growth-led phases, tracking differences, and market risk should be checked in advance. It is also a good idea to compare it with simple value and active value products.

CheckpointWhat to checkCurrent status
🔬 Research enhancementReview research score selectionResearch reflected
📊 Value orientationReview undervalued stock exposureValue reflected
🔄 Style rotationReview value and growth phasesNeeds checking
💵 Expense ratioCheck fees for rules-based managementOn the low side

Relative weakness in growth-led phases and tracking differences from research score selection are the main variables for long-term performance, and the selection process can make its composition differ from a general value index. Even with a focus on value stocks, losses can occur during market crashes.

It is a suitable candidate for value-oriented investors who want to invest in US value stocks screened with research. If you want a value factor or active value exposure, it is advisable to compare products such as VLUE and JAVA, and if you want research-enhanced value exposure, to consider this product alongside them.

Briefs · earnings · signals, first Subscribe

Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.

This article reflects information as of June 10, 2026.

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →